Use of Metabolic Inert Mycobacterium abscessus Cells to Study the Efficiency Of Drugs
- Authors: Martini B.A.1, Salina E.G.1,2
- 
							Affiliations: 
							- A.N. Bach Institute of Biochemistry, Research Center of Biotechnologies Russian Academy of Sciences
- Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences
 
- Issue: Vol 59, No 6 (2023)
- Pages: 599-604
- Section: Articles
- URL: https://cardiosomatics.ru/0555-1099/article/view/674590
- DOI: https://doi.org/10.31857/S0555109923060089
- EDN: https://elibrary.ru/CKTHEU
- ID: 674590
Cite item
Abstract
We investigated the effectiveness of antibiotics (amikacin, bedaquiline, linezolid, moxifloxacin, rifampicin) on metabolically inert M. abscessus obtained under conditions of potassium deficiency in vitro. It was found that bedaquiline led to a significant decrease in the ability of bacteria to form colonies on solid media, but did not lead to their death, since it was shown that during cultivation in a liquid medium, they reverted to a state of active division and growth. Moxifloxacin had a bactericidal effect against metabolically inert bacteria, irreversibly and significantly reducing the number of viable cells in culture, which emphasizes the effectiveness of its use for the treatment of infections caused by M. abscessus.
About the authors
B. A. Martini
A.N. Bach Institute of Biochemistry, Research Center of Biotechnologies Russian Academy of Sciences
														Email: elenasalina@yandex.ru
				                					                																			                												                								Russia, 119071, Moscow						
E. G. Salina
A.N. Bach Institute of Biochemistry, Research Center of Biotechnologies Russian Academy of Sciences; Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences
							Author for correspondence.
							Email: elenasalina@yandex.ru
				                					                																			                												                								Russia, 119071, Moscow; Russia, 117997, Moscow						
References
- Johansen M.D., Herrmann J.L., Kremer L. // Nat. Rev. Microbiol. 2020. V. 18. № 1. P. 392–407. https://doi.org/10.1038/s41579-020-0331-1
- Recchia D., Stelitano G., Stamilla A., Gutierrez D.L., Degiacomi G., Chiarelli L.R., Pasca M.R. // Int. J. Mol. Sci. 2023. V. 24. № 5. P. 4635. https://doi.org/10.3390/ijms24054635
- Sepulcri C., Vena A., Bassetti M. // Curr. Opin. Infect. Dis. 2023. V. 36. № 2. P. 74–80. https://doi.org/10.1097/QCO.0000000000000905
- Berube B.J., Castro L., Russell D., Ovechkina Y., Parish T. // Front Microbiol. 2018. V. 9. P. 2417. https://doi.org/10.3389/fmicb.2018.02417
- Yam Y.K., Alvarez N., Go M.L., Dick T. // Front Microbiol. 2020. V. 11. P. 359. https://doi.org/10.3389/fmicb.2020.00359
- Shleeva M., Mukamolova G.V., Young M., Williams H.D., Kaprelyants A.S. // Microbiology. 2004. V. 150. P. 1687–1697. https://doi.org/10.1099/mic.0.26893-0
- Salina E.G., Waddell S.J., Hoffmann N., Rosenkrands I., Butcher P.D., Kaprelyants A.S. // Open Biol. 2014. V. 4. P. 140106. https://doi.org/10.1098/rsob.140106
- Connell N. // Methods Cell Biol. 1994. V. 45 P. 107–125. https://doi.org/10.1016/s0091-679x(08)61848-8
- Shleeva M.O., Kudykina Y.K., Vostroknutova G.N., Suzina N.E., Mulyukin A.L., Kaprelyants A.S. // Tuberculosis (Edinb). 2011. V. 91. P. 146–154. https://doi.org/10.1016/j.tube.2010.12.006
- de Man J.C. // J. Appl. Microbiol. 1975. V. 1. P. 67–78. https://doi.org/10.1007/BF01880621
- Palomino J.C., Martin A., Camacho M., Guerra H., Swings J., Portaels F. // Antimicrob. Agents Chemother. 2002. V. 46. № 8. P. 2720–2722. https://doi.org/10.1128/AAC.46.8.2720-2722.2002
- Coban A.Y., Deveci A., Sunter A.T., Palomino J.C., Martin A. // Int J Mycobacteriol. 2014. V. 3. № 4. P. 230–241. https://doi.org/10.1016/j.ijmyco.2014.09.002
- Performance Standards for Antimicrobial Susceptibility Testing. // Clinical and Laboratiry Standard Institute Wayne, V. 27(1). 17th Information Supplement.
- Myers A. // J. Biol. Educ. 1990. V. 24. № 2. P. 123–127. https://doi.org/10.1080/00219266.1990.9655123
- Salina E., Ryabova O., Kaprelyants A., Makarov V. // Antimicrob. Agents Chemother. 2014. V.58. № 1. P. 55–60. https://doi.org/10.1128/AAC.01308-13
- Hurst-Hess K.R., Saxena A., Rudra P., Yang Y., Ghosh P. // Mol. Cell. 2022. V.82. № 17. P. 3166–3177. https://doi.org/10.1016/j.molcel.2022.06.034
- Vesenbeckh S., Schönfeld N., Roth A., Bettermann G., Krieger D., Bauer T.T., Rüssmann H., Mauch H. // Eur. Respir. J. 2017. V. 49. № 5. P. 1700083. https://doi.org/10.1183/13993003.00083-2017
 
				
			 
					 
						 
						 
						 
						 
									

 
  
  
  Email this article
			Email this article 
 Open Access
		                                Open Access Access granted
						Access granted Subscription or Fee Access
		                                							Subscription or Fee Access
		                                					

